Aerosol delivery aspects within a high-flow therapy system in COPD patients
There is a lack of information about the influence of patient interfaces such as facemasks or mouthpieces on the effective dose of aerosolised drugs while using high-flow therapy in a clinical setting. These interfaces can improve pulmonary drug delivery over nasal cannulas but patient preference an...
Main Authors: | Yasmin M. Madney, Nabila Ibrahim Laz, Ahmed A. Elberry, Hoda Rabea, Mohamed E.A. Abdelrahim |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2021-01-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/7/1/00422-2020.full |
Similar Items
-
The efficacy of oral versus parentral vitamin D in treatment of nutritional rickets
by: Hoda M. Rabea, et al.
Published: (2012-12-01) -
Noninvasive ventilation usage time and survival rate in patients with acute respiratory failure: some key insights
by: Yasmin M. Madney, et al.
Published: (2020-07-01) -
Effect of diuretics on the plasma brain natriuretic peptide (BNP) level in patients with an acute exacerbation of COPD
by: Randa Salah El Deen Mohammad, et al.
Published: (2017-07-01) -
Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with COPD and asthma: protocol for a randomised controlled trial
by: Jian Luo, et al.
Published: (2019-06-01) -
Effect of DPI's training-device on inhalation technique and clinical efficacy in asthmatics
by: Mina Nicola, et al.
Published: (2018-06-01)